Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Long-Term Investments (2019 - 2020)

Historic Long-Term Investments for Silence Therapeutics (SLN) over the last 2 years, with Q4 2020 value amounting to $400096.6.

  • Silence Therapeutics' Long-Term Investments rose 1315.77% to $400096.6 in Q4 2020 from the same period last year, while for Dec 2020 it was $400096.6, marking a year-over-year increase of 1315.77%. This contributed to the annual value of $389096.3 for FY2020, which is 1081.24% up from last year.
  • As of Q4 2020, Silence Therapeutics' Long-Term Investments stood at $400096.6, which was up 1315.77% from $353574.3 recorded in Q4 2019.
  • Silence Therapeutics' Long-Term Investments' 5-year high stood at $400096.6 during Q4 2020, with a 5-year trough of $353574.3 in Q4 2019.